Alpha Cognition Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Alpha Cognition Inc. (ACOG) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $1.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-13
- Alpha Cognition Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $1.45M, a 4.57% increase year-over-year.
- Alpha Cognition Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $1.40M, a 24.09% increase year-over-year.
- Alpha Cognition Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-12-31 was -$204.22K.
- Alpha Cognition Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $1.07M, a 454.39% increase year-over-year.
- Alpha Cognition Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $3.77M, a 353.61% increase from fiscal 2024.
- Alpha Cognition Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $831.74K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.45M 10-Q · filed 2026-08-13 | $2.86M 10-Q · filed 2026-08-13 | $2.65M derived: sum of 3 quarters · filed 2026-08-13 | $3.73M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $1.40M 10-Q · filed 2026-05-14 | $1.20M derived: sum of 2 quarters · filed 2026-05-14 | $2.27M derived: sum of 3 quarters · filed 2026-05-14 | $3.66M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$204.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $869.86K derived: sum of 2 quarters · filed 2026-03-31 | $2.26M derived: sum of 3 quarters · filed 2026-08-13 | $3.77M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $1.07M 10-Q · filed 2025-11-13 | $2.46M derived: sum of 2 quarters · filed 2026-08-13 | $3.98M 10-Q · filed 2025-11-13 | $3.51M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $1.39M 10-Q · filed 2026-08-13 | $1.55M 10-Q · filed 2025-08-14 | $2.52M 10-Q · filed 2026-08-13 | $2.90M 10-Q · filed 2025-08-14 | $2.43M derived: sum of 3 quarters · filed 2026-08-13 | $2.63M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.13M 10-Q · filed 2026-05-14 | $1.36M 10-Q · filed 2025-05-15 | $1.05M derived: sum of 2 quarters · filed 2026-05-14 | $1.24M derived: sum of 3 quarters · filed 2026-05-14 | $1.61M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$85.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $108.32K derived: sum of 2 quarters · filed 2026-03-31 | $483.65K derived: sum of 3 quarters · filed 2026-03-31 | $831.74K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $193.74K 10-Q · filed 2025-11-13 | $569.07K derived: sum of 2 quarters · filed 2025-11-13 | $917.15K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $375.33K 10-Q · filed 2025-08-14 | $723.41K 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $348.08K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |